Asana Inc. buy BiotechBee
Start price
01.10.23
/
50%
€17.55
Target price
31.10.25
€20.00
Performance (%)
20.60%
End price
02.12.23
€21.17
Summary
This prediction ended on 02.12.23 with a price of €21.17. The prediction had a final performance of 20.60%. BiotechBee has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Asana Inc. | 0.820% | 0.820% | -46.053% |
| iShares Core DAX® | 0.734% | -0.964% | 17.910% |
| iShares Nasdaq 100 | -2.686% | -2.409% | 4.267% |
| iShares Nikkei 225® | -2.261% | -4.038% | 10.420% |
| iShares S&P 500 | -1.346% | -1.510% | 1.615% |
According to BiotechBee what are the pros and cons of Asana Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Asana Inc. diskutieren
Buy mit Kursziel 20,0
In the thread Trading Asana Inc.
Buy beendet

